Company Profile

SUVEN LIFE SCIENCES LTD.

NSE : SUVENBSE : 530239ISIN CODE : INE495B01038Industry : Pharmaceuticals & DrugsHouse : Private
BSE96.00-1.85 (-1.89 % )
PREV CLOSE (Rs.) 97.85
OPEN PRICE (Rs.) 98.45
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 119545
TODAY'S LOW / HIGH (Rs.)95.50 99.55
52 WK LOW / HIGH (Rs.)30.45 115.8
NSE96.00 -1.75 (-1.79 % )
PREV CLOSE(Rs.) 97.75
OPEN PRICE (Rs.) 97.80
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 96.00 (449 )
VOLUME 526393
TODAY'S LOW / HIGH(Rs.) 95.50 99.60
52 WK LOW / HIGH (Rs.)30.5 116

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.00
TTM EPS (Rs.) -1.78
P/E Ratio 0.00
Book Value (Rs.) 29.98
Face Value (Rs.) 1
MCap (Rs. in Mn) 12219.12
Price/Earning (TTM) -66.83
Price/Sales (TTM) 90.66
Price/Book (MRQ) 3.20
PAT Margin (%) -95.41
ROCE (%) -6.40
Incorporation Year : 1989

Management Info :

Venkateswarlu Jasti - Chairman - Managing Director

Registered Office :

Address : 8-2-334, S D E Serene Chambers,6th Floor, Road No 5, Avenue 7,Banjara Hills,
Hyderabad,
Telangana-500034

Phone : +91-40- 23541142 23543311 32921695 32921696

Email : info@suven.com

Website : www.suven.com

Registrar's Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS More
05May05-05-2021$Suven Life Sciences informs about newspaper advertisement Suven Life Sciences informs
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, Suven Life Sciences has informed that it has enclosed the copies of the newspaper advertisement regarding Audited Financial Results of the Company for quarter and Financial Year ended 31st March, 2021. The advertisements are as appeared on 05th May, 2021 in Business Standard and Andhra Prabha (Telugu). The above information will also be hosted on the website of the Company at: http://www.suven.com/newspaperads.aspx

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 47 of the SEBI (Listing Obligations and..
28Apr04-28-2021$Suven Life Sciences informs about newspaper advertisement Suven Life Sciences informs

In continuation to its letter dated April 27th, 2021 regarding the Date and Notice of Board Meeting, Suven Life Sciences has informed that it has enclosed the copies of the newspaper advertisements as appeared today, April 28th, 2021 in ‘Andhra Prabha (Telugu) and Business Standard’. The above information will also be hosted on the website of the Company at: http://www.suven.com/newspaperads.aspx.

The above information is a part of company’s filings submitted to BSE.

In continuation to its letter dated April 27th, 2021 regarding..
25Feb02-25-2021$ Announcement under Regulation 30 (LODR)-Preferential Issue Announcement under Regulati
Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015 and other applicable provisions of law, please find enclosed the Notice of Extra-Ordinary General Meeting (EGM) of Suven Life Sciences Limited ('the Company') to be held on Saturday, 20th March, 2021 at 11.30 a.m. (IST) through video conference ('VC') / other audio-visual means ('OAVM'). The Notice of EGM has been dispatched electronically to the members whose email IDs are registered with the Company/ Depositories. The Notice of EGM is also uploaded on the Company's website at www.suven.com. This is for your information and record.
Pursuant to the provisions of Regulation 30 of the SEBI (LODR)..
22Feb02-22-2021$ Outcome Of The Board Meeting Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Outcome Of The Board Meetin
Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015, as amended and other applicable provisions of law, we wish to inform you that the Board of Directors of the company at its meeting held today i.e. 20th February, 2021 has inter-alia considered and approved the following: 1. Issuance of 1,81,00,000 (One Crore Eighty-One Lakh) fully Convertible Warrants on Preferential Basis to the Promoter/ Promoter Group (details as annexed) of the company in accordance with the provisions of the Companies Act, 2013, Chapter V of the SEBI (lssue of Capital and Disclosure Requirements) Regulations, 2018 and other applicable statutory provisions and subject to the approval of shareholders in the Extra-Ordinary General Meeting of the Company;
Pursuant to the provisions of Regulation 30 of the SEBI (LODR)..
22Feb02-22-2021$Allotment of Convertible warrants Allotment of Convertible war
inter alia, approved: 1.Issuance of 1,81,00,000 (One Crore Eighty-One Lakh) fully Convertible Warrants on Preferential Basis to the Promoter/ Promoter Group (details as annexed) of the company in accordance with the provisions of the Companies Act, 2013, Chapter V of the SEBI (lssue of Capital and Disclosure Requirements) Regulations, 2018 and other applicable statutory provisions and subject to the approval of shareholders in the Extra-Ordinary General Meeting of the Company; The price at which the warrants will be issued shall be determined in accordance with provisions of chapter V of SEBI (lssue of capital and Disclosure Requirements) Regulations, 2018 as amended. 2.Notice convening the Extra-Ordinary General Meeting of the Company to be held on Saturday, 20th March, 2021seeking the approval of the Shareholders of the Company for the issuance of fully convertible warrants on preferential basis.
inter alia, approved: 1.Issuance of 1,81,00,000 (One Crore..
Financials More
Rs. in Millions
QTR Mar 21 ANNUAL 21
Net Profit-85.09-226.31
Gross Profit -84.63 -279.54
Operating Profit -71.55-227.93
Net Sales 15.57134.78
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
NGL Fine-Chem (BSE)
 1679.60 (4.62%)
M.Cap ( in Cr)
1037.66
Ajanta Pharma (BSE)
 2002.95 (3.11%)
M.Cap ( in Cr)
17331.88
Solara Active Pharma (BSE)
 1742.70 (2.80%)
M.Cap ( in Cr)
6261.48
Themis Medicare (BSE)
 465.55 (5.54%)
M.Cap ( in Cr)
427.77
Cadila Healthcare (BSE)
 646.95 (2.74%)
M.Cap ( in Cr)
66231.03
Shareholding Pattern More
PROMOTERS 60 %
NON-INSTITUTION 38.86 %
MUTUAL FUNDS/UTI 0.21 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
Scheme NameHold(%)
L&T Emerging Opp Fund-I...0.53
F & O Quotes